Answer
Clarithromycin potently inhibits CYP3A4 and may increase exposure to dasatinib, so coadministration is not recommended.
Sources for this answer
- Dasatinib 100 mg film-coated tabletsMSN Laboratories Europe Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked